Appian Corporation Class A APPN 深 沪
已收盘 11-28 16:00:00 美东时间
40.40
-0.680
-1.66%
华盛通- 最 高41.27
- 今 开41.08
- 成交量 28.54万股
- 最 低 40.18
- 昨 收 41.08
- 总市值 29.99亿
- 52周最高 46.059
- 市盈率 静 --
- 换手率 0.38%
- 52周最低 24.00
- 委 比 77.52%
- 总股本 7422.82万
- 历史最高 260.00
- 量 比 0.47
- 振 幅 2.65%
- 历史最低 15.229
- 每 手 1
- 风险率 3.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Appian Names 2025 Public Sector Partner Award Winners
MCLEAN, Va., Nov. 20, 2025 /PRNewswire/ -- At this year's Appian Government conference, Appian (Nasdaq: APPN) announced the winners of its 2025 Appian Government Partner Impact and Excellenc...
11-21 01:24
Appian AI Transforms Clinical Workflows for Global Public Health Agencies
Appian and Ignyte Group Win Global HL7 AI Challenge for ethical, proactive healthcare innovation. MCLEAN, Va., Nov. 20, 2025 /PRNewswire/ -- Appian (Nasdaq: APPN), a leader in AI process aut...
11-20 22:00
Shares of software stocks are trading lower amid broader tech weakness as AI-linked stocks sell off.
Shares of software stocks are trading lower amid broader tech weakness as AI-li...
11-14 03:13
Appian Unveils Next-Gen AI Agents To Transform Enterprise Automation
Appian Corp launches new AI capabilities to automate complex work and accelerate app modernization. Appian's AI agents can reason.
11-13 02:51
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
11-12 11:43
Sibanye pays $215M to settle dispute over canceled nickel mining deal
Sibanye-Stillwater (SBSW) +4.7% in Monday's trading after saying it agreed to pay $215 million to Appian Capital Advisory to settle a legal dispute over the miner's termination of a $1.2 billion deal ...
11-11 00:28
Osisko development reports Q3 results
Osisko development press release (ODV): Q3 Revenue of $4.4M. ~$401.4 million in cash and cash equivalents Drawn ~$137.2 million (US$100.0 million) under the US$450 million Appian financing facility ex...
11-10 21:42
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
Osisko Development Reports Third Quarter 2025 Results
Osisko Development Corp. reported Q3 2025 financial and operational highlights, including $401.4 million in cash, $137.2 million drawn under a $450 million credit facility, and $280.4 million raised through private placements. The company advanced pre-construction activities at the Cariboo Gold Project, released ore sorting test results, and sold 877 ounces of gold from the Tintic heap leach project. Subsequent to Q3, the company completed an add...
11-10 12:00
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
